Duloxetine Versus Placebo in the Treatment of Elderly Patients With Generalized Anxiety Disorder.
Phase of Trial: Phase IV
Latest Information Update: 13 Oct 2015
At a glance
- Drugs Duloxetine (Primary)
- Indications Generalised anxiety disorder
- Focus Pharmacogenomic; Therapeutic Use
- Sponsors Eli Lilly
- 13 Oct 2015 Primary endpoint has been met.
- 01 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.